EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Effect on Pain Following One Session of Botulinum Toxin Type A in Patients With Jaw Myalgia: A Randomised Double‐Blind Controlled Multicentre Pilot Study

Ava Minston iD, Helene Abrahamsson iD, Peter Abrahamsson iD, Erik Lindfors iD, Eva Nohlert iD, Daniel Ovesson iD, Negin Yekkalam iD, Göran Isacsson iD

Journal of Oral Rehabilitation · 2025-05 · 52 (5) · 587-596

DOI: 10.1111/joor.13915 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Oral Rehabilitation, online erschienen am 29.12.2024. Verfasst von Ava Minston und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orofacial Pain and Jaw Function, Postgraduate Dental Education Center, Public Dental Health Service, Örebro, Sweden. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Neuromuscular Agents, Masseter Muscle, Myalgia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Folktandvården, Örebro Läns Landsting, Regionala Forskningsrådet Uppsala/Örebro, Landstinget Västmanland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Botulinum toxin Type A (BTX‐A) is increasingly used in the management of myofascial pain; however, the evidence to support this treatment modality is still inconclusive.

Objective

To evaluate the change in days with functional jaw pain after one session of BTX‐A or placebo injections into the masseter and temporalis muscles in subjects with jaw myalgia. The hypothesis was that BTX‐A is effective in reducing the number of days with functional jaw pain.

Methods

This was a randomised, double‐blind, parallel group study in subjects with jaw myalgia. After randomisation, BTX‐A or placebo injections were made in the masseter and temporalis muscles. The number of days with jaw pain on function was evaluated after 2 months. Adverse events were registered.

Results

Twenty‐three subjects were randomly assigned to BTX‐A and 22 to placebo. Between baseline and the 2‐month follow‐up, the number of days with jaw pain at function changed from a median (interquartile range) of 14 (4) to 10.5 (6) days in the BTX‐A group and from 14.0 (1.5) to 14 (5) in the saline group ( p < 0.585). Adverse events were mild and transient and similar in the two groups.

Conclusion

A single treatment of BTX‐A injections in the masseter and temporalis muscles was not effective in treating jaw myalgia. However, an adequately powered study might provide sufficient support for efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Botulinum Toxins, Type ANeuromuscular AgentsMasseter MuscleMyalgiaFacial PainHumansDouble-Blind MethodPilot ProjectsFemaleMaleMiddle AgedTreatment OutcomePain MeasurementInjections, IntramuscularAdultTemporal Muscle

Stichwörter der Autor:innen

botulinum toxin type Amyofascial painorofacial paintemporomandibular disorderstreatment

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Orofacial Pain and Jaw Function, Postgraduate Dental Education Center, Public Dental Health Service, Örebro, Sweden.
  • Department of Orofacial Pain and Jaw Function, Aqua Dental Specialist Clinic, Stockholm, Sweden.
  • The Maxillofacial Unit, Halmstad Hospital, Halmstad, Sweden.
  • Department of Oral and Maxillofacial Surgery and Oral Medicine, Malmö University, Malmö, Sweden.
  • Department of Orofacial Pain and Jaw Function, Public Dental Health Service, Uppsala, Sweden.
  • Region Vastmanland-Uppsala University, Centre for Clinical Research, Västmanland Hospital, Västerås, Sweden.

ORCID-Profile: Ava Minston, Helene Abrahamsson, Peter Abrahamsson, Erik Lindfors, Eva Nohlert, Daniel Ovesson, Negin Yekkalam, Göran Isacsson

Förderung

  • Folktandvården, Örebro Läns Landsting
  • Regionala Forskningsrådet Uppsala/Örebro
  • Landstinget Västmanland

Zitieren

APA

Minston, A., Abrahamsson, H., Abrahamsson, P., Lindfors, E., Nohlert, E., Ovesson, D., Yekkalam, N., & Isacsson, G. (2025). Effect on Pain Following One Session of Botulinum Toxin Type A in Patients With Jaw Myalgia: A Randomised Double‐Blind Controlled Multicentre Pilot Study. Journal of Oral Rehabilitation, 52(5), 587-596. https://doi.org/10.1111/joor.13915

Vancouver

Minston A, Abrahamsson H, Abrahamsson P, Lindfors E, Nohlert E, Ovesson D, et al. Effect on Pain Following One Session of Botulinum Toxin Type A in Patients With Jaw Myalgia: A Randomised Double‐Blind Controlled Multicentre Pilot Study. Journal of Oral Rehabilitation. 2025;52(5):587-596. doi:10.1111/joor.13915

BibTeX
@article{Minston2025,
  author = {Minston, Ava and Abrahamsson, Helene and Abrahamsson, Peter and Lindfors, Erik and Nohlert, Eva and Ovesson, Daniel and Yekkalam, Negin and Isacsson, Göran},
  title = {Effect on Pain Following One Session of Botulinum Toxin Type A in Patients With Jaw Myalgia: A Randomised Double‐Blind Controlled Multicentre Pilot Study},
  journal = {Journal of Oral Rehabilitation},
  year = {2025},
  volume = {52},
  number = {5},
  pages = {587--596},
  doi = {10.1111/joor.13915}
}
Kostenlos starten →